Cormorant Asset Management’s Twist Bioscience TWST Stock Holding History

Cormorant Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-185,000	Closed	-$24.7M	–	103
2021 Q2	$24.7M	Hold	185,000	–	–	0.84%	34
2021 Q1	$22.9M	Sell	185,000 -40,000	-18%	-$6.07M	0.51%	43
2020 Q4	$31.8M	Sell	225,000 -275,000	-55%	-$30.5M	0.76%	35
2020 Q3	$38M	Sell	500,000 -52,849	-10%	-$3.29M	1.46%	23
2020 Q2	$25M	Sell	552,849 -134,300	-20%	-$4.82M	0.96%	33
2020 Q1	$21M	Hold	687,149	–	–	0.98%	32
2019 Q4	$14.4M	Hold	687,149	–	–	0.58%	43
2019 Q3	$16.4M	Sell	687,149 -18,915	-3%	-$550K	1%	34
2019 Q2	$20.5M	Hold	706,064	–	–	1.18%	31
2019 Q1	$16.4M	Hold	706,064	–	–	1.11%	31
2018 Q4	$16.3M	Buy	+706,064	New	+$15.6M	1.32%	30

Other funds holding TWST

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Cormorant Asset Management's TWST Position: Q3 2021 in Review

Cormorant Asset Management sold out of Twist Bioscience (TWST) in Q3 2021, closing a stake of 185,000 shares — an estimated $24.7M sold.

Cormorant Asset Management first reported a position in TWST in Q4 2018 and held it in 11 quarters. The position peaked at $38M in Q3 2020. 236 funds tracked by Wall St. Rank hold TWST as of Q3 2021.

Cormorant Asset Management reported no remaining Twist Bioscience position as of Q3 2021 after selling out during the quarter.
Cormorant Asset Management sold 185,000 Twist Bioscience shares in Q3 2021, an estimated $24.7M.
Cormorant Asset Management first reported a position in Twist Bioscience in Q4 2018 and held it in 11 quarters.
Cormorant Asset Management's Twist Bioscience position peaked at $38M in Q3 2020.
236 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2021.

Based on Cormorant Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.